Panel

Noticias Financieras

Google AdSenseNews Headernews_header
Diagnostics-on-wheels innovation offers ‘huge potential for national rollout’
med_technewshace 20d

Diagnostics-on-wheels innovation offers ‘huge potential for national rollout’

A ‘groundbreaking’ vehicle which is taking radiography into the community while helping to reduce hospital admissions has ‘huge potential for national rollout which must be tapped into’. That’s the view of a Scottish healthcare innovation specialist which continues to encourage Allied Health Professionals (AHPs) like radiographers to collaboratively develop their fresh ideas for better patient [...]The post Diagnostics-on-wheels innovation offers ‘huge potential for national rollout’ appeared first on Med-Tech Insights.

#TECH
Insights Ahead: Freeport-McMoRan's Quarterly Earnings
benzingahace 20d

Insights Ahead: Freeport-McMoRan's Quarterly Earnings

Freeport-McMoRan (NYSE:FCX) is gearing up to announce its quarterly earnings on Thursday, 2026-01-22. Here's a quick overview of what investors should know before the release.Analysts are estimating that Freeport-McMoRan will report an earnings per share (EPS) of $0.30.The market awaits Freeport-McMoRan's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It's important for new investors to understand that guidance can be a significant driver of stock prices.Overview of Past EarningsLast quarter the company beat EPS by $0.09, which was followed by a 0.34% increase in the share price the next day.Here's a look at Freeport-McMoRan's past performance and the resulting price change:QuarterQ3 2025Q2 2025Q1 2025Q4 2024EPS Estimate0.410.450.240.22EPS Actual0.500.540.240.31Price Change %0.00-1.00-1.00-2.00Tracking Freeport-McMoRan's Stock PerformanceShares of Freeport-McMoRan were trading at $60.07 as of January 20. Over the last 52-week period, shares are up 56.03%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. Analyst Views on Freeport-McMoRanFor investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Freeport-McMoRan.A total of 10 analyst ratings have been received for Freeport-McMoRan, with the consensus rating being Outperform. The average one-year price target stands at $56.1, ...Full story available on Benzinga.com

#COMMODITIES
Google AdSenseNews Footernews_footer